The Clorox Company (NYSE:CLX) Shares Sold by Webster Bank N. A.

Webster Bank N. A. cut its holdings in shares of The Clorox Company (NYSE:CLX) by 20.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 380 shares of the company’s stock after selling 100 shares during the quarter. Webster Bank N. A.’s holdings in Clorox were worth $62,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Integrated Advisors Network LLC increased its holdings in Clorox by 15.1% in the 4th quarter. Integrated Advisors Network LLC now owns 3,338 shares of the company’s stock valued at $476,000 after purchasing an additional 437 shares during the last quarter. Syon Capital LLC purchased a new position in shares of Clorox in the 4th quarter valued at $284,000. EP Wealth Advisors LLC raised its stake in Clorox by 4.0% during the 4th quarter. EP Wealth Advisors LLC now owns 6,810 shares of the company’s stock worth $971,000 after acquiring an additional 263 shares in the last quarter. Richardson Financial Services Inc. purchased a new stake in Clorox in the fourth quarter valued at $51,000. Finally, Fisher Asset Management LLC boosted its stake in Clorox by 2.2% in the fourth quarter. Fisher Asset Management LLC now owns 22,966 shares of the company’s stock valued at $3,275,000 after acquiring an additional 493 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Insider Buying and Selling

In other news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.51% of the stock is currently owned by insiders.

Clorox Stock Up 1.4 %

CLX stock opened at $160.30 on Monday. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63. The firm has a market capitalization of $19.91 billion, a PE ratio of 83.06, a P/E/G ratio of 3.19 and a beta of 0.41. The Clorox Company has a 12 month low of $114.68 and a 12 month high of $169.09. The company’s 50 day simple moving average is $157.36 and its 200-day simple moving average is $144.72.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.28. The business had revenue of $1.90 billion for the quarter, compared to the consensus estimate of $1.97 billion. Clorox had a net margin of 3.95% and a return on equity of 281.12%. Equities analysts expect that The Clorox Company will post 6.64 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be paid a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 3.04%. The ex-dividend date is Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is 252.85%.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on CLX. TD Cowen began coverage on Clorox in a report on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 target price for the company. Wells Fargo & Company lowered their target price on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a research report on Wednesday, July 10th. Deutsche Bank Aktiengesellschaft upped their price target on shares of Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Citigroup lifted their price objective on shares of Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. Finally, JPMorgan Chase & Co. increased their target price on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research note on Friday. Six investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $150.36.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.